Pap smear (Conventional smear) is the most widely used cervical cancer screening test in the world. Negative intraepithelial lesion for malignancy, squamous intraepithelial lesion and cervical cancer remain important health problems for women worldwide. In developing countries like India, there is a great need for mass screening program for cervical lesion.
Aims and objectives: To assess the clinician utility of The 2014 Bethesda System Reporting of cervical epithelial abnormalities.
Material and methods: All the cervical cytology Pap smears received in Department of Pathology Vishwabharti Medical College, Kurnool, A.P were retrieved and reviewed in the duration of 1 years from 2017 - 2018.
Results: A total number of 110 cases of Pap smears were retrieved during period of study, out of which 83.6% were satisfactory for evaluation; 17.3% were within normal limit and 64.5% were NILM. A few (8.2%) of the cases were reported as squamous intraepithelial lesion; 7.3% ASCUS.
Conclusion: Pap smear is a proven tested tool for making an early diagnosis and treating cervical cancer in early stage. Thus, Pap smear is simple, less expensive diagnostics tool suitable for implementation in India. The Bethesda system used for cervical cytology is not only a uniform and standard method but also gives descriptive diagnosis that helps the gynaecologist in individualized patient management.